These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1195 related items for PubMed ID: 16636336

  • 1. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    Cancer and Leukemia Group B 89901Massachusetts General Hospital Cancer Center, Boston MA 02114, USA. dpryan@partners.org, Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, Goldberg RM, Mayer RJ.
    J Clin Oncol; 2006 Jun 01; 24(16):2557-62. PubMed ID: 16636336
    [Abstract] [Full Text] [Related]

  • 2. Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study.
    François E, Ychou M, Ducreux M, Bertheault-Cvitkovic F, Giovannini M, Conroy T, Lemanski C, Thomas O, Magnin V, Groupe Digestif de la Fédération Nationale des Centres de Lutte Contre le Cancer.
    Eur J Cancer; 2005 Dec 01; 41(18):2861-7. PubMed ID: 16297614
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
    Caravatta L, Padula GD, Picardi V, Macchia G, Deodato F, Massaccesi M, Sofo L, Pacelli F, Rotondi F, Cecere G, Sallustio G, Di Lullo L, Piscopo A, Mignogna S, Bonomo P, Cellini N, Valentini V, Morganti AG.
    Acta Oncol; 2011 Nov 01; 50(8):1151-7. PubMed ID: 21851185
    [Abstract] [Full Text] [Related]

  • 6. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y, Ohtsu A, Boku N, Miyata Y, Shimada Y, Doi T, Muro K, Muto M, Hamaguchi T, Mera K, Yano T, Tanigawara Y, Shirao K.
    Jpn J Clin Oncol; 2006 Apr 01; 36(4):218-23. PubMed ID: 16684860
    [Abstract] [Full Text] [Related]

  • 7. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 8. Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.
    Hospers GA, Punt CJ, Tesselaar ME, Cats A, Havenga K, Leer JW, Marijnen CA, Jansen EP, Van Krieken HH, Wiggers T, Van de Velde CJ, Mulder NH.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2773-9. PubMed ID: 17653805
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Fakih MG, Rajput A, Yang GY, Pendyala L, Toth K, Smith JL, Lawrence DD, Rustum YM.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1462-70. PubMed ID: 16750332
    [Abstract] [Full Text] [Related]

  • 13. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ.
    Acta Oncol; 2007 Aug 01; 46(3):336-41. PubMed ID: 17450469
    [Abstract] [Full Text] [Related]

  • 14. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
    Marsh RD, Chu NM, Vauthey JN, Mendenhall WM, Lauwers GY, Bewsher C, Copeland EM.
    Cancer; 1996 Jul 15; 78(2):217-25. PubMed ID: 8673995
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer.
    Hong YS, Lee JL, Park JH, Kim JH, Yoon SN, Lim SB, Yu CS, Kim MJ, Jang SJ, Lee JS, Kim JC, Kim TW.
    Int J Radiat Oncol Biol Phys; 2011 Mar 01; 79(3):684-9. PubMed ID: 20452140
    [Abstract] [Full Text] [Related]

  • 17. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L, Bai C, Shao Y, Guan M, Jia N, Xiao Y, Qiu H, Zhang F, Yang T, Zhong G, Chen S.
    Cancer Lett; 2011 Nov 28; 310(2):134-9. PubMed ID: 21782322
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.
    Acta Oncol; 2008 Nov 28; 47(3):428-33. PubMed ID: 18348002
    [Abstract] [Full Text] [Related]

  • 19. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer.
    Urso E, Serpentini S, Pucciarelli S, De Salvo GL, Friso ML, Fabris G, Lonardi S, Ferraro B, Bruttocao A, Aschele C, Nitti D.
    Eur J Surg Oncol; 2006 Dec 28; 32(10):1201-8. PubMed ID: 16872799
    [Abstract] [Full Text] [Related]

  • 20. Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
    Bertolini F, Chiara S, Bengala C, Antognoni P, Dealis C, Zironi S, Malavasi N, Scolaro T, Depenni R, Jovic G, Sonaglio C, Rossi A, Luppi G, Conte PF.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):466-72. PubMed ID: 19004567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.